Followers | 1072 |
Posts | 136569 |
Boards Moderated | 1 |
Alias Born | 08/25/2010 |
Friday, February 09, 2018 10:18:59 AM
Prior to current positions, Mr. Chan served as Managing Director at Evidia Biosciences, a clinical laboratory and pathology service provider consists of 3 labs servicing over 700 physicians in Southern California and Pennsylvania; Vice President at Amphastar Pharmaceutical, (NASDAQ:AMPH); and Director of International Society of Pharmaceutical Engineers (ISPE, 18,000 members in 90 countries worldwide) LA. Ch. Mr. Chan started his investment banking career back in 1990 as Operation Manager of Tse's Investment Ltd., the investment division of TSL, Ltd. (0417.HK), running stock and forex investment floor with 6 trading offices throughout HK.
Everything I say is in my opinion, do your own DD and make your decision wisely! Don't spend more then you can afford to lose!
Recent AAGH News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/09/2024 07:42:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 09:05:21 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/30/2024 12:59:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 05:14:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:53:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 06:14:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 05:07:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/03/2024 01:12:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 08:49:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/23/2024 10:01:42 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/12/2024 09:31:50 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 02/08/2024 08:36:35 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/08/2024 08:32:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 07:56:14 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 11/16/2023 07:40:43 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/01/2023 12:52:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 01:45:16 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM